We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Has Community Health Found the Right Prescription for its Debt Burden?
Read MoreHide Full Article
Key Takeaways
Community Health has reduced debt and improved its leverage metrics.
Rising occupancy and portfolio streamlining are supporting EBITDA growth.
CYH still carries far higher leverage than hospital giants HCA and Tenet.
Community Health Systems, Inc. (CYH - Free Report) still carries a debt load that dwarfs its equity value. At the end of the first quarter, long-term debt stood at $10.13 billion, while cash and cash equivalents jumped to $712 million from $260 million at 2025-end. In comparison, the company’s market capitalization is only about $427 million. Its net debt-to-capital ratio of 106.1% remains well above the industry average of 65.6%.
The balance sheet did not become stretched overnight. A heavily leveraged acquisition of Health Management Associates in 2014 left the company with billions in debt that never produced the expected returns. Since then, management has shifted gears. Long-term debt has fallen from $13.4 billion at the end of 2019 through asset sales and the retirement of expensive debt.
Image Source: Zacks Investment Research
The question today is no longer whether CYH can reduce debt. It already has. The bigger issue is whether it can keep growing EBITDA while bringing leverage down. Net debt-to-EBITDA has improved to 6.79 from a five-year median of 8.48. Adjusted EBITDA topped $1.5 billion in both 2024 and 2025, and management expects a stronger second half of 2026.
Recent divestitures, including three Pennsylvania hospitals, Crestwood Medical Center and its stake in Tennova Healthcare-Clarksville, have sharpened the portfolio. Occupancy improved from 52% at the end of 2025 to 55.4% in the first quarter, suggesting the turnaround is gaining traction.
How Are Major Hospitals Positioned?
CYH is not the only hospital operator with significant debt, but its leverage remains much higher than its peers. One of its major peers, HCA Healthcare, Inc. (HCA - Free Report) , carries long-term debt of around $39.5 billion at first-quarter end, down 5.1% from 2025-end, and Tenet Healthcare Corporation (THC - Free Report) has long-term debt, net of the current portion, of $13.1 billion, which inched up marginally from 2025-end. However, stronger earnings and cash flow keep their leverage ratios lower. HCA Healthcare and Tenet Healthcare currently have net debt-to-EBITDA of 3.22 and 2.81, respectively.
CYH’s Price Performance, Valuation and Estimates
Shares of CYH have declined 2.9% year to date, outperforming the broader industry’s decline of 17.2%.
Image Source: Zacks Investment Research
From a valuation standpoint, CYH trades at a forward price-to-sales ratio of 0.04X, down from the industry average of 0.55X. CYH carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CYH’s 2026 earnings implies a 148.7% deterioration year over year, followed by 71.3% improvement next year.
View the Zacks #1 Rank List
Image: Bigstock
Has Community Health Found the Right Prescription for its Debt Burden?
Key Takeaways
Community Health Systems, Inc. (CYH - Free Report) still carries a debt load that dwarfs its equity value. At the end of the first quarter, long-term debt stood at $10.13 billion, while cash and cash equivalents jumped to $712 million from $260 million at 2025-end. In comparison, the company’s market capitalization is only about $427 million. Its net debt-to-capital ratio of 106.1% remains well above the industry average of 65.6%.
The balance sheet did not become stretched overnight. A heavily leveraged acquisition of Health Management Associates in 2014 left the company with billions in debt that never produced the expected returns. Since then, management has shifted gears. Long-term debt has fallen from $13.4 billion at the end of 2019 through asset sales and the retirement of expensive debt.
The question today is no longer whether CYH can reduce debt. It already has. The bigger issue is whether it can keep growing EBITDA while bringing leverage down. Net debt-to-EBITDA has improved to 6.79 from a five-year median of 8.48. Adjusted EBITDA topped $1.5 billion in both 2024 and 2025, and management expects a stronger second half of 2026.
Recent divestitures, including three Pennsylvania hospitals, Crestwood Medical Center and its stake in Tennova Healthcare-Clarksville, have sharpened the portfolio. Occupancy improved from 52% at the end of 2025 to 55.4% in the first quarter, suggesting the turnaround is gaining traction.
How Are Major Hospitals Positioned?
CYH is not the only hospital operator with significant debt, but its leverage remains much higher than its peers. One of its major peers, HCA Healthcare, Inc. (HCA - Free Report) , carries long-term debt of around $39.5 billion at first-quarter end, down 5.1% from 2025-end, and Tenet Healthcare Corporation (THC - Free Report) has long-term debt, net of the current portion, of $13.1 billion, which inched up marginally from 2025-end. However, stronger earnings and cash flow keep their leverage ratios lower. HCA Healthcare and Tenet Healthcare currently have net debt-to-EBITDA of 3.22 and 2.81, respectively.
CYH’s Price Performance, Valuation and Estimates
Shares of CYH have declined 2.9% year to date, outperforming the broader industry’s decline of 17.2%.
From a valuation standpoint, CYH trades at a forward price-to-sales ratio of 0.04X, down from the industry average of 0.55X. CYH carries a Value Score of A.
The Zacks Consensus Estimate for CYH’s 2026 earnings implies a 148.7% deterioration year over year, followed by 71.3% improvement next year.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.